Search Results - UYLDEGROOT, C

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits

    Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits by Uyl-de Groot, C.A., Vermorken, J.B., Hanna, M.G., Verboom, P., Groot, M.T., Bonsel, G.J., Meijer, C.J.L.M., Pinedo, H.M.

    Published in Vaccine
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    A cost-utility analysis comparing intensive chemotherapy alone to intensive chemotherapy followed by myeloablative chemotherapy with autologous stem-cell rescue in newly diagnosed patients with stage II/III multiple myelomaa prospective randomised phase III study

    A cost-utility analysis comparing intensive chemotherapy alone to intensive chemotherapy followed by myeloablative chemotherapy with autologous stem-cell rescue in newly diagnosed... by VANAGTHOVEN, M, SEGEREN, C, BUIJT, I, UYLDEGROOT, C, VANDERHOLT, B, LOKHORST, H, SONNEVELD, P

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    European School of Oncology advisory report to the Commission of the European Communities for the “Europe against cancer programme” cost-effectiveness in cancer care

    European School of Oncology advisory report to the Commission of the European Communities for the “Europe against cancer programme” cost-effectiveness in cancer care by Williams, C., Coyle, D., Gray, A., Hutton, J., Jefferson, T., Karlsson, G., Kesteloot, K., Uyl-de Groot, C., Wait, S.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Treatment costs and quality of life with granulocyte-macrophage colony-stimulating factor in patients with antineoplastic therapy-related febrile neutropenia. Results of a randomised placebo-controlled trial

    Treatment costs and quality of life with granulocyte-macrophage colony-stimulating factor in patients with antineoplastic therapy-related febrile neutropenia. Results of a randomis... by Uyl-de Groot, C A, Vellenga, E, de Vries, E G, Löwenberg, B, Stoter, G J, Rutten, F F

    Published in PharmacoEconomics
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: